Cardiac conduction system and myocardial tissue (CCS)

The cardiac conduction system and myocardial tissue constitute the functional units of the heart responsible for generating and propagating electrical impulses that trigger coordinated muscular contraction (StatPearls, 2023). The conduction system includes the sinoatrial node, atrioventricular node, bundle of His, and Purkinje fibers, while the myocardium consists of specialized cardiomyocytes (NIH, 2022). These tissues are essential for maintaining rhythmic heartbeats and efficient blood circulation throughout the body. Pathologies in these tissues lead to conditions such as arrhythmias, heart failure, and myocardial infarction (PubMed, 2021). Pharmacological interventions typically target specific ion channels (e.g., SCN5A, KCNH2) or receptors (e.g., ADRB1) within these tissues to manage heart rate, rhythm, and contractile force (PubChem, 2024). Understanding the integrated function of these tissues is critical for developing cardiovascular therapies and assessing drug-induced cardiotoxicity, such as QT interval prolongation (FDA, 2023). Clinical monitoring of these tissues often involves electrocardiography (ECG) and the measurement of cardiac-specific biomarkers like troponins (StatPearls, 2023).

Other names

Heart conduction systemCardiac electrical systemMyocardiumCardiac muscle tissueCardiac conduction system / Myocardial tissue

Drugs targeting this system typically modulate the activity of ion channels (e.g., sodium, potassium, and calcium channels) or cell surface receptors (e.g., beta-adrenergic receptors) to alter the rate, rhythm, or force of cardiac contraction (StatPearls, 2023).